Home  >  News
Corporate
+ Font Resize -

UK healthcare’s most innovative cos in oncology to participate in India-UK Healthcare Leadership Forum

Our Bureau, Mumbai
Friday, November 10, 2017, 16:15 Hrs  [IST]

A delegation of 12 UK based innovative companies in oncology will take part in India-UK Healthcare Leadership Forum to be held in Mumbai on November 13.

The delegation comprising of NHS trust hospitals, universities and private healthcare firms--- The Christie NHS Foundation Trust, Northumbria Healthcare NHS Foundation Trust, Northumbria Healthcare NHS Foundation Trust, Great Ormond Street Hospital (GOSH) for Children, CIS Oncology Ltd, Paxman Coolers Ltd, University of Manchester, Cambridgene Ltd, Elsevier Ltd, Cancer Care Commission, Renaissance, TexRad Ltd-- was in Bengaluru from November 9-12 to attend the 2nd Indian Cancer Congress.

Mumbai forum is jointly organised by the UK's Department for International Trade, British Deputy High Commission, Mumbai in collaboration with Confederation of Indian Industry (CII).

India is expected to see 1.45 million new cases of cancer in 2016 rising to 1.73 million new cases by 2020 (National Cancer Registry). Oral, breast, lung, cervical cancers are among the leading causes of deaths in India. India requires new technology in every aspect of this disease be it prediction through genetics, early detection, new treatment protocols and medical equipment. There is no greater collective threat to the health of our citizens than that posed by long term conditions such as cancer.

India and the UK share common goals in this regard. The UK is at the forefront of cancer research, as well as the development and introduction of new technologies. The NHS has a cancer strategy to improve cancer prevention, diagnosis, treatment and end-of-life care. The NHS and UK companies have compelling offers in cancer for overseas health systems covering advanced laboratory diagnostics including the latest genomic testing, provision of leading edge cancer services, development of the latest clinical protocols to achieve high quality clinical outcomes, R&D collaborations with potential for longer term partnerships in specific clinical areas, unmatched data assets to underpin research and the full range of education and training in cancer for doctors, nurses and technical staff.

Crispin Simon, British Deputy High Commissioner, Western India and Director General of Department for International Trade, India & South Asia said, “The UK has a clear focus to transform healthcare service delivery through integrated healthcare systems, emergency and acute medicine in and out of hospital. With an unmatched combination of clinical, technological and academic expertise, the UK is ideally placed to play a significant role in working with India in the transformation of its healthcare goals. I hope that through our delegation, we will help build some ground-breaking partnerships in overcoming the specific healthcare challenge in India.”

“We are also helping Indian businesses access the best of advanced British technology in healthcare by taking Indian delegations across the UK as a part of the India-UK Future TECH month. This is a very good platform for both the UK and India to work together for improved healthcare in India,” said  Simon.

In Mumbai, Indian companies will get an opportunity to network with UK healthcare firms and find out about opportunities for collaboration. The UK has an unmatched combination of clinical, technological and academic expertise.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
PITS_2017
Pre-Connect Congress 2017
acssymposium
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |